Respiratory changes in parkinson's disease may be unrelated to dopaminergic dysfunction;Alterações respiratórias na doença de parkinson podem não ter relação com a disfunção dopaminérgica

Arquivos de Neuro-Psiquiatria

Volumn 70, Issue 11, 2012, Pages 847-851

  Guedes, Luciana Ulhôa ^a   Rodrigues, Juliana Melo ^b   Fernandes, Aline Andrioni ^a   Cardoso, Francisco E ^a   Parreira, Verônica Franco ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hospital Sarah Kubitschek   (Brazil)

Author keywords

Assessment; Breathing; Levodopa; Muscle strength; Parkinson's disease

Indexed keywords

DOPAMINE; LEVODOPA;

ADULT; AGED; AIRWAY PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; MALE; MAXIMAL EXPIRATORY PRESSURE; MAXIMAL INSPIRATORY PRESSURE; PARKINSON DISEASE; RATING SCALE; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SPIROMETRY;

EID: 84873924415     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2012001100005     Document Type: Article

References (25)

1. Vincken WG, Gauthier SG, Dollfuss RE, Hanson RE, Darauay CM, Cosio MG. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med 1984;311:438-442.
2. Hovestadt A, Bogaard JM, Meerwaldt JD, van der Meché FG, Stigt J. Pulmonary function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989;52:329-333.
3. Fontana GA, Pantaleo T, Lavorini F, Benvenuti F, Gangemi S. Defective motor control of coughing in Parkinson's disease. Am J Respir Crit Care Med 1998;158:458-464.
4. de Bruin PF, de Bruin VM, Lees AJ, Pride NB. Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson's disease. Am Rev Respir Dis 1993;148:1576-1580.
5. Sabaté M, Rodríguez M, Méndez E, Enríquez E, González I. Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson disease. Arch Phys Med Rehabil 1996;77:29-34.
6. Haas BM, Trew M, Castle PC. Effects of respiratory muscle weakness on daily living function, quality of life, activity levels, and exercise capacity in mild to moderate Parkinson's disease. Am J Phys Med Rehabil 2004;83:601-607.
7. Silverman EP, Sapienza CM, Saleem A, et al. Tutorial on maximum inspiratory and expiratory mouth pressures in individuals with idiopathic Parkinson disease (IPD) and the preliminary results of an expiratory muscle strength training program. NeuroRehabilitation 2006;21:71-79.
8. Tzelepis GE, McCool FD, Friedman JH, Hoppin FG Jr. Respiratory muscle dysfunction in Parkinson's disease. Am Rev Respir Dis 1988;138:266-271.
9. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99:696-702.
10. McConnell AK, Copestake AJ. Maximum static respiratory pressures in healthy elderly men and women: issues of reproducibility and interpretation. Respiration 1999;66:251-258.
11. Berry JK, Vitalo CA, Larson JL, Patel M, Kim MJ. Respiratory muscle strength in older adults. Nurs Res 1996;45:154-159.
12. Canning CG, Alison JA, Allen NE, Groeller H. Parkinson's disease: an investigation of exercise capacity, respiratory function, and gait. Arch Phys Med Rehabil 1997;78:199-207.
13. Cardoso SR, Pereira JS. [Analysis of breathing function in Parkinson's disease]. Arq Neuropsiquiatr 2002;60:91-95.
14. Enright PL, Kronmal RA, Manolio TA, Schenker MB, Hyatt RE. Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group. Am J Respir Crit Care Med 1994;149:430-438.
15. Weiner P, Inzelberg R, Davidovich A, et al. Respiratory muscle performance and the Perception of dyspnea in Parkinson's disease. Can J Neurol Sci 2002;29:68-72.
16. Vincken WG, Darauay CM, Cosio MG. Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease. Chest 1989;96:210-212.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55: 181-184.
18. Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res 1999;32:719-727.
19. Fahn S, Elton R, and members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M (eds). Recent development in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information; 1987: 153-164.
20. Harik-Khan RI, Wise RA, Fozard JL. Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med 1998;158:1459-1464.
21. Hunter PC, Crameri J, Austin S, Woodward MC, Hughes AJ. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry 1997; 63:579-583.
22. Morris M, Iansek R, McGinley J, Matyas T, Huxham F. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder. Mov Disord 2005;20:40-50.
23. Obenour WH, Stevens PM, Cohen AA, McCutchen JJ. The causes of abnormal pulmonary function in Parkinson's disease. Am Rev Respir Dis 1972;105:382-387.
24. Rice JE, Antic R, Thompson PD. Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease. Mov Disord 2002;17: 524-527.
25. Hautmann H, Hefele S, Schotten K, Huber RM. Maximal inspiratory mouth pressures (PIMAX) in healthy subjects--what is the lower limit of normal? Respir Med 2000;94:689-693.